Skip to main content

and
  1. Article

    Open Access

    Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells

    Pancreatic ductal adenocarcinoma (PDAC), the fourth leading cause of cancer death, has a 5-year survival rate of approximately 7–9%. The ineffectiveness of anti-PDAC therapies is believed to be due to the exis...

    Sandra Valle, Sonia Alcalá, Laura Martin-Hijano in Nature Communications (2020)

  2. No Access

    Article

    Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance

    Pancreatic ductal adenocarcinoma (PDAC) is an inherently chemoresistant tumor. Chemotherapy leads to apoptosis of cancer cells, and in previous studies we have shown that tumor-associated macrophage (TAM) infi...

    Gabriele D’Errico, Marta Alonso-Nocelo, Mireia Vallespinos, Patrick C. Hermann in Oncogene (2019)

  3. Article

    Open Access

    Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer

    Knowledge on the molecular mechanisms underlying metastasis colonization in Non-Small Cell Lung Cancer (NSCLC) remains incomplete. A complete overview integrating driver mutations, primary tumour heterogeneity...

    Javier Mariscal, Marta Alonso-Nocelo, Laura Muinelo-Romay in Scientific Reports (2016)

  4. Article

    Open Access

    Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node

    Metastases are the most common reason of cancer death in patients with solid tumors. Lymph nodes, once invaded by tumor cells, act as reservoirs before cancer cells spread to distant organs. To address the lim...

    Marta Alonso-Nocelo, Raquel Abellan-Pose, Anxo Vidal in Journal of Nanobiotechnology (2016)